Author
Listed:
- Zeting Zang
- Humayun Kabir
- Tom Scott
Abstract
Purpose - This study is motivated by changes to the accounting for equity financial instruments (EFAs) under International Financial Reporting Standard (IFRS) 9 Financial Instruments. This study aims to improve understanding of firms’ EFA usage, classification choices and the value relevance of EFA information before and after IFRS 9. Design/methodology/approach - Using a sample of Australian Securities Exchange 500 firms, including financial and non-financial firms, the authors examine the use of EFA, its classification determinants and usefulness using descriptive statistics, logit models and value relevance models. Findings - The authors find no change in the frequency of EFA after IFRS 9, differing from evidence in other jurisdictions. The determinants appear to have changed from being driven by the impact on earnings, indicative of an opportunistic motivation, to the size of the EFA post-IFRS 9 in non-financial firms. There is no change in the value relevance of the EFA amount post-IFRS 9. Practical implications - This study contributes to the International Accounting Standard Board’s understanding of the implementation of IFRS 9. Specifically, the authors add to the debate on whether to recycle fair value gains or losses on EFAs by showing that there is no impact on firms’ use of EFA in practice. Originality/value - To the best of the authors’ knowledge, this study is one of the first to examine accounting choices and the usefulness of accounting information for EFAs in both financial and non-financial firms in the context of the standard change.
Suggested Citation
Zeting Zang & Humayun Kabir & Tom Scott, 2025.
"Equity financial instruments: use, determinants and usefulness from IAS 39 to IFRS 9,"
Meditari Accountancy Research, Emerald Group Publishing Limited, vol. 33(7), pages 417-442, May.
Handle:
RePEc:eme:medarp:medar-03-2025-2930
DOI: 10.1108/MEDAR-03-2025-2930
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eme:medarp:medar-03-2025-2930. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Emerald Support (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.